查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881567

穿戴式注射器市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、技術、應用、地區和競爭格局分類，2020-2030年預測

Wearable Injectors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Application, by Region, and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球穿戴式注射器市場規模為86.2億美元，預計到2030年將以9.89%的複合年成長率成長至151.8億美元。穿戴式注射器是一種緊湊型醫療設備，用於控制皮下藥物輸送，佩戴在身上，方便患者進行便捷、隱藏的給藥。該市場的成長主要得益於全球慢性病盛行率的上升（需要持續的自我治療）以及對居家醫療保健解決方案日益成長的需求，這些解決方案能夠增強患者的自主性。

市場概覽
預測期 2026-2030
2024年市場規模 86.2億美元
2030年市場規模 151.8億美元
2025-2030年複合年成長率 9.89%
成長最快的細分市場 身體上
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球穿戴式注射器市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（貼身、非貼身）
    • 依技術類型（環形、馬達驅動、旋轉幫浦、膨脹電池、其他）
    • 依應用領域（腫瘤科、傳染病科、心血管疾病科、自體免疫疾病科、免疫缺陷科及其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美穿戴式注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲穿戴式注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區穿戴式注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲穿戴式注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲穿戴式注射器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球穿戴式注射器市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Becton & Dickinson Co.
  • Johnson & Johnson Service Inc.
  • F. Hoffmann-La Roche Ltd.
  • Frederick Furness Publishing Ltd
  • Steady Med Therapeutics, Inc (United Therapeutics Corporation)
  • Amgen Inc.
  • Insulet Corporation
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • CeQur SA

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21528

The Global Wearable Injectors Market, valued at USD 8.62 Billion in 2024, is projected to experience a CAGR of 9.89% to reach USD 15.18 Billion by 2030. Wearable injectors are compact medical devices designed for controlled subcutaneous drug delivery, worn on the body to facilitate convenient and discreet medication administration. Growth in this market is primarily supported by the increasing global prevalence of chronic diseases requiring continuous self-treatment and the expanding demand for home-based healthcare solutions, which enhance patient autonomy.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.62 Billion
Market Size 2030USD 15.18 Billion
CAGR 2025-20309.89%
Fastest Growing SegmentOn-Body
Largest MarketNorth America

Key Market Drivers

The increasing global prevalence of chronic diseases represents a primary driver for the wearable injectors market, necessitating continuous and often complex drug administration. Conditions like diabetes, cardiovascular disease, and autoimmune disorders demand regular, precise dosing over extended periods, making convenient delivery crucial. Wearable injectors offer an effective solution, enabling patients to manage therapies outside clinical settings, thereby supporting adherence and improving quality of life. Addressing this expanding patient population, according to Novo Nordisk, February 2025, Novo Nordisk Annual Report 2024, the company served over 45.2 million people living with serious chronic diseases in 2024, highlighting the critical demand for accessible drug delivery systems.

Key Market Challenges

The high initial cost associated with developing advanced wearable injectors presents a significant challenge to the Global Wearable Injectors Market. This substantial financial outlay directly hampers market expansion by elevating the final product price, which can limit widespread adoption. Such cost implications are particularly pronounced in regions with constrained healthcare budgets or limited reimbursement coverage, making these innovative devices less accessible to a broader patient population requiring continuous self-treatment.

Key Market Trends

Seamless digital integration and remote monitoring are transforming wearable injectors by embedding connectivity for real-time data exchange and patient oversight. This capability allows for continuous tracking of adherence, device performance, and patient physiological responses, leading to more informed treatment adjustments. According to France Biotech, in 2023, remote monitoring solutions demonstrated the highest growth in the digital health sector, increasing by four points compared to 2022 to represent 14% of digital health products. This integration supports decentralized care by extending clinical supervision into the home setting, improving patient safety and engagement.

Key Market Players

  • Becton & Dickinson Co.
  • Johnson & Johnson Service Inc.
  • F. Hoffmann-La Roche Ltd.
  • Frederick Furness Publishing Ltd
  • Steady Med Therapeutics, Inc (United Therapeutics Corporation)
  • Amgen Inc.
  • Insulet Corporation
  • Enable Injections
  • West Pharmaceutical Services, Inc.
  • CeQur SA

Report Scope:

In this report, the Global Wearable Injectors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wearable Injectors Market, By Type:

  • On-body
  • Off-body

Wearable Injectors Market, By Technology:

  • Spring-based
  • Motor-driven
  • Rotary Pump
  • Expanding Battery
  • Other

Wearable Injectors Market, By Application:

  • Oncology
  • Infectious Disease
  • Cardiovascular Disease
  • Autoimmune Disease
  • Immunodeficiency
  • others

Wearable Injectors Market, By Region:

  • North America
  • South America
  • Asia Pacific
  • Europe
  • MEA

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Wearable Injectors Market.

Available Customizations:

Global Wearable Injectors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wearable Injectors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (On-body, Off-body)
    • 5.2.2. By Technology (ring-based, Motor-driven, Rotary Pump, Expanding Battery, Other)
    • 5.2.3. By Application (Oncology, Infectious Disease, Cardiovascular Disease, Autoimmune Disease, Immunodeficiency, others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Wearable Injectors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Wearable Injectors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Wearable Injectors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Wearable Injectors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application

7. Europe Wearable Injectors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Wearable Injectors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. France Wearable Injectors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Wearable Injectors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Wearable Injectors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Wearable Injectors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application

8. Asia Pacific Wearable Injectors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Wearable Injectors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. India Wearable Injectors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Wearable Injectors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Wearable Injectors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Wearable Injectors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Middle East & Africa Wearable Injectors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Wearable Injectors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Wearable Injectors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Wearable Injectors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application

10. South America Wearable Injectors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Wearable Injectors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Wearable Injectors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Wearable Injectors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Wearable Injectors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton & Dickinson Co.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Johnson & Johnson Service Inc.
  • 15.3. F. Hoffmann-La Roche Ltd.
  • 15.4. Frederick Furness Publishing Ltd
  • 15.5. Steady Med Therapeutics, Inc (United Therapeutics Corporation)
  • 15.6. Amgen Inc.
  • 15.7. Insulet Corporation
  • 15.8. Enable Injections
  • 15.9. West Pharmaceutical Services, Inc.
  • 15.10. CeQur SA

16. Strategic Recommendations

17. About Us & Disclaimer